Works matching DE "CYTOCHROME P-450 CYP2C19"
Results: 280
The role of CYP2C19*2 variant and other factors in clopidogrel resistance in Montenegrin ACS patients.
- Published in:
- Genetics & Applications, 2024, v. 8, n. 2, p. 54, doi. 10.31383/ga.vol8iss2ga03
- By:
- Publication type:
- Article
Pharmacogenomic profiling of variants affecting efficacy and toxicity of anti-infective medicines in a south Asian population from Sri Lanka.
- Published in:
- BMC Infectious Diseases, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12879-025-10538-w
- By:
- Publication type:
- Article
The impact of CYP2C19 genotypes on steady-state plasma concentration of escitalopram in South Indian population with Major Depressive Disorder.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e123645
- By:
- Publication type:
- Article
10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis.
- Published in:
- Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12833
- By:
- Publication type:
- Article
From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1326776
- By:
- Publication type:
- Article
Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1216433
- By:
- Publication type:
- Article
The impact of CYP2C19 genotype on phenoconversion by concomitant medication.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1201906
- By:
- Publication type:
- Article
Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.719671
- By:
- Publication type:
- Article
The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta‐analysis.
- Published in:
- Mycoses, 2021, v. 64, n. 8, p. 860, doi. 10.1111/myc.13293
- By:
- Publication type:
- Article
Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17.
- Published in:
- PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245401
- By:
- Publication type:
- Article
Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0236260
- By:
- Publication type:
- Article
Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
- Published in:
- Military Medicine, 2024, v. 189, n. 1/2, p. e198, doi. 10.1093/milmed/usad254
- By:
- Publication type:
- Article
Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients.
- Published in:
- BMC Neurology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12883-021-02127-6
- By:
- Publication type:
- Article
CYP2C19 loss-of-function is associated with increased risk of hypertension in a Hakka population: a case-control study.
- Published in:
- BMC Cardiovascular Disorders, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12872-023-03207-w
- By:
- Publication type:
- Article
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1397, doi. 10.1007/s10557-023-07534-0
- By:
- Publication type:
- Article
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 447, doi. 10.1007/s10557-022-07392-2
- By:
- Publication type:
- Article
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1147, doi. 10.1007/s10557-021-07142-w
- By:
- Publication type:
- Article
Advancements in physiologically based pharmacokinetic modeling for fedratinib: updating dose guidance in the presence of a dual inhibitor of CYP3A4 and CYP2C19.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 4, p. 549, doi. 10.1007/s00280-024-04696-y
- By:
- Publication type:
- Article
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 193, doi. 10.1007/s00280-023-04554-3
- By:
- Publication type:
- Article
CYP2C19 POLYMORPHISMS ON ESCITALOPRAM TREATMENT OUTCOME IN SOUTH INDIAN POPULATION WITH MAJOR DEPRESSIVE DISORDER.
- Published in:
- ScienceRise: Pharmaceutical Science, 2024, v. 49, n. 3, p. 110, doi. 10.15587/2706-5448.2024.307289
- By:
- Publication type:
- Article
CYP2C19 POLYMORPHISMS ON ESCITALOPRAM TREATMENT OUTCOME IN SOUTH INDIAN POPULATION WITH MAJOR DEPRESSIVE DISORDER.
- Published in:
- ScienceRise: Pharmaceutical Science, 2024, v. 49, n. 3, p. 70, doi. 10.15587/2519-4852.2024.307289
- By:
- Publication type:
- Article
Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2024, v. 7, n. 3, p. 238, doi. 10.1093/jcag/gwae005
- By:
- Publication type:
- Article
Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3992, doi. 10.3390/jcm10173992
- By:
- Publication type:
- Article
Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3964, doi. 10.3390/jcm10173964
- By:
- Publication type:
- Article
Pharmacogenomics in Psychiatry: An Asian Perspective.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Systematic review of economic evaluation studies in psychiatric pharmacogenomics.
- Published in:
- European Psychiatry, 2021, v. 64, p. S382, doi. 10.1192/j.eurpsy.2021.1024
- By:
- Publication type:
- Article
Investigation of Radiotracer Metabolic Stability In Vitro with CYP-Overexpressing Hepatoma Cell Lines.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 15, p. 2447, doi. 10.3390/cells11152447
- By:
- Publication type:
- Article
Effect of deglucuronidation on the results of the Basel phenotyping cocktail.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4608, doi. 10.1111/bcp.14874
- By:
- Publication type:
- Article
Clinical treatment for hepatitis C reverses CYP2C19 inhibition.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 4013, doi. 10.1111/bcp.14829
- By:
- Publication type:
- Article
Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P‐gp and BCRP.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 7, p. 2926, doi. 10.1111/bcp.14707
- By:
- Publication type:
- Article
Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2021, v. 14, p. 1379, doi. 10.2147/PGPM.S329662
- By:
- Publication type:
- Article
Effect on emergence from anesthesia following induction with diazepam and its association with CYP2C9, CYP2C19 and CYP3A4 gene polymorphisms.
- Published in:
- Anaesthesia, Pain & Intensive Care, 2024, v. 28, n. 1, p. 126, doi. 10.35975/apic.v28i1.2380
- By:
- Publication type:
- Article
The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s43042-022-00313-w
- By:
- Publication type:
- Article
Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0288794
- By:
- Publication type:
- Article
Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1121, doi. 10.1002/cpt.3378
- By:
- Publication type:
- Article
Assessing the Performance of In silico Tools and Molecular Dynamics Simulations for Predicting Pharmacogenetic Variant Impact.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1082, doi. 10.1002/cpt.3348
- By:
- Publication type:
- Article
Association of Pharmacogenomic Phenotypes in CYP2D6, CYP2C9, CYP2C19, and CYP3A5 on Polypharmacy in Veterans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 2, p. 390, doi. 10.1002/cpt.3297
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling to Investigate the Disease‐Drug–Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID‐19 Patients with CYP2C19 Phenotypes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 2, p. 363, doi. 10.1002/cpt.3222
- By:
- Publication type:
- Article
Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 204, doi. 10.1002/cpt.3270
- By:
- Publication type:
- Article
Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1141, doi. 10.1002/cpt.3183
- By:
- Publication type:
- Article
CYP2C19 Loss‐of‐Function Variants Associated With Long‐Term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 1126, doi. 10.1002/cpt.3028
- By:
- Publication type:
- Article
High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 1104, doi. 10.1002/cpt.3026
- By:
- Publication type:
- Article
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 1033, doi. 10.1002/cpt.3012
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling and Simulation of Mavacamten Exposure with Drug–Drug Interactions from CYP Inducers and Inhibitors by CYP2C19 Phenotype.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 922, doi. 10.1002/cpt.3005
- By:
- Publication type:
- Article
Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 693, doi. 10.1002/cpt.2973
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 51, doi. 10.1002/cpt.2903
- By:
- Publication type:
- Article
3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1284, doi. 10.1002/cpt.2887
- By:
- Publication type:
- Article
Evaluation of Potential Racial Disparities in CYP2C19‐Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 615, doi. 10.1002/cpt.2776
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 5, p. 959, doi. 10.1002/cpt.2526
- By:
- Publication type:
- Article